OB Flashcards
Goodell’s Sign
Softening of cervix at 4-6wk
Chadwick’s Sign
Bluish discolouration of cervix and vagina due to pelvic vasculature engorgement at 6wk
Hegar’s sign
Softening of cervical isthmus at 6-8wks
beta-hCG
Peptide hormone composed of alpha and beta subunits produced by placental trophoblastic cells
Maintains corpus luteum during pregnancy
beta hCG positive levels at…
9d post-conception in serum
28d after first day of LMP in urine
beta-hCG plasma level pattern
Doubles every 1.4-2d for first 4 weeks, then by 6-7wks may take 3d to double, peaks at 8-10wks then falls to plateau until delivery
beta-hCG levels less than expected suggest
Ectopic
Abortion
Inaccurate dates
May be normal
beta-hCG levels higher than expected suggest
Multiple gestation
Molar pregnancy
Trisomy 21
Inaccurate dates
beta-hCG rule of 10s
10IU = time of missed menses
100 000 IU = 10wk (peak)
10 000 IU = term
Transvaginal U/S finding at 5wks
Gestational sac
Transvaginal U/S finding at 6 wk
Fetal pole
Transvaginal U/S finding at 7-8wks
Fetal heart activity
Transabdominal U/S finding at 6-8wk
Intrauterine pregnancy visible
First trimester
1-14wks
Second trimester
14-28wks
Third trimester
28-42wks
Change in Hb and Hct in pregnancy
Decrease (physiologic anemia secondary to hemodilution)
Leukocyte count change in pregnancy
Increase but with impaired function
Gestational thrombocytopenia
Mild (plt >70 000) and asymptomatic, normalizes within 2-12wk
Hormone involved with delayed gastric emptying
Progesterone
Causes GERD, gallstones, constipation
Ureters and renal pelvis dilation in pregnancy
R>L
Secondary to progesterone induced sooth muscle relaxation and uterine enlargement
Renal function changes in pregnancy
Increased CO --> increased GFR Decreased Cr (35-44mmol/L), uric acid and BUN
Thyroid changes in pregnancy
Increased total thyroxine and thyroxine binding globulin
TSH levels are normal
Cortisol levels in pregnancy
Rise throughout
Calcium levels in pregnancy
Decreased total Calcium due to decreased albumin (free ionized Ca2+ remains the same due to parathyroid hormone)
Folic acid
8-12wks preconception until end of T1
Prevent NTDs
0.4-1mg daily in all women
5mg if previous NTD, antieplieptic meds, DM or BMI > 35kg/m2
Naegle’s Rule of dating
1st day of LMP + 1yr + 7d - 3mo
Dates should change if T1 U/S differs by…
> 5d in difference from LMP due date
Diclectin
10mg doxylamine succinate with Vitamin B6
4 tabs PO daily (1 qAM, 1qlunch, 2 qhs)
Up to max of 8 tabs/d
OB causes associated with hyperemesis
Multiple gestation
GTN
HELLP Syndrome
Kleihauer-Betke test
Extent of fetomaternal hemorrhage by estimating volume of fetal blood that entered maternal circulation
Situations when Rhogam is given to Rh neg women
Routinely at 28wk GA (protection for 12wk)
Within 72h of birth of an Rh+ fetus
Invasive procedure in pregnancy (CVS, amnio)
Ectopic preg
Miscarriage or therapeutic abortion
Antepartum hemorrhage
trauma
Tx for Rh neg and Ab pos mom
Follow serial monthly Ab titres throughout pregnancy, U/S +/- serial amnios as needed
Fetal hydrops
Edema in at least 2 fetal compartments due to fetal HF secondary to anemia
Erythroblastosis fetalis
Mod-severe immune-mediated hemolytic anemia
Risk factors for NTD
GRIMM
Genetics (risk of 2nd child having NTD is 2-5%, increased from baseline risk of 0.1%)
Race: Europeans>Africans, 3x higher in hispanics
Insufficient folate and zinc
Maternal chronic dz
maternal use of antiepileptics
Primigravidas feel fetal mvmt at
18-20wks
Normal EFM tracing
Baseline: 110-160bpm
Variability: 6-25bpm (< / = 5bpm for < 40min)
Decels: None, early decels, occasional uncomplicated, variable decels
Accels (term): Spontaneous, accels of >/= 15bpm lasting 15s
Accels (preterm): accels of > / = 10bpm last 10s
Accels present with scalp stim
Atypical EFM tracing
Baseline: 100-110 or >160 for <30min to < 80min
Variability: < / = 5bpm (absent or minimal) for 40-80min
Decels: Repetitive (> / = 3) uncomplicated variable decels. Occasional late decels. Single prolonged deceleration > 2 min but < 3 min
Accels: absence with fetal scalp stimulation
Abnormal EFM tracing
Baseline: Brady <100, tachy >160 for >80min
Variability: < 5 for > 80min, sinusoidal, >/=25bpm for >10min
Decels: Repetitive (> / = 3) complicated variable decels, late decels, any prolonged decel (> / = 3)
Accels: Nearly absent
Biophysical profile
U/S assessment +/- NST
Scoring: 2 points for each if reassuring
Tone (at least one epi of limb extension followed by flexion)
Movement (3 discrete mvmts)
breathing (at least one epi of breathing lasting at least 30s)
Amniotic fluid volume (fluid pocket of 2cm in 2 axes)
LAMB Limb extension and flexion AFV Movement Breathing
8-10 = normal 6 = unequivocal =4 = deliver
Daily caloric intake during pregnancy
100cal/d in 1st trimester
300 cal/d in 2nd and 3rd trimester
450 cal/d during lactation
Only nutrient for which requirements during pregnancy can’t be met by diet alone
Iron
Absolute C/I to exercise
Ruptured membranes preterm labour HTN d/o of preg Incompetent cervix IUGR Multiple gestations (>3) Placenta previa after 28th wk Persistent 2nd or 3rd trimester bleeding Unctrolled Type 1 DM Uncontrolled thyroid dz Other srs CV, resp or systemic d/o
Relative C/I to exercise
Previous preterm birth Mild/mod cv or resp d/o anemia (=100g/L) Malnutrition or eating d/o Twin preg after 28th wk
Smoking in pregnancy associated with
Decreased birth weight Placenta previa/abruption Spontaneous abortion Preterm labour Stillbirth
Cocaine in pregnancy associated with
Microcephaly
Growth retardation
Prematurity
Abruptio placentae
Marijuana in pregnancy associated with
Low birth weight
NSAIDs in pregnancy associated with
Premature closure of the ductus arteriosus after 30wks GA
Vaccines safe in pregnancy
Tetanus Diphtheria Influenza Hep B Pertussis
Vaccines recommended in pregnancy
Influenza
Tdap (irrespective of immunization hx) ideally btwn 27-32wks
Hepatitis B if maternal status unknown or positive
Hep B Vaccine and HBIG should be given to infant within 12h of birth with F/U doses at 1 and 6mo
Most common pathological etiology of obstetrical hemorrhage in T3
Abruptio placentae
Placenta previa
Abnormal location of placenta near, partially or completely over the internal cervical os
0.5-0.8% of all pregnancies
Painless bleeding
Abruptio placentae
Premature separation of a normally implanted placenta after 20wk GA
1-2% of all pregnancies
Painful bleeding
Placenta previa risk factors
- Hx of placenta prevue (4-8% recurrence risk)
- Multiparity
- Increased maternal age
- Multiple gestation
- Uterine tumour (ie. fibroids) to other uterine anomalies
- Uterine scar due to previous abortion, C/S, D&C, myomectomy
Abruptio placenta risk factors
- Previous abruption (recurrence rate 5-16%)
- Maternal HTN (chronic or gestational HTN in 50% of abruptions) or vascular dz
- Cigarette smoking (>1 pack/d), excessive EtOH consumption, cocaine
- Multiparity and/or maternal age >35yr
- PPROM
- Rapid decompression of a distended uterus (polyhydramnios, multiple gestation)
- Uterine anomaly, fibroids
- Trauma
Spontaneous resolution of placenta previa is likely if…
placenta obscures internal os by <20mm at 20wk GA
Transvaginal U/S should be repeated in third trimester
NIPT
Analyzes blood for circulating cell free fetal DNA at 9-10wk GA onwards
Highly sensitive/specific for Trisomy 21 (can also look for tri 18, 13 and some X and Y disorders)
Doesn’t screen for ONTD
NIPT indications
> 35 yo
Abnormal prenatal screen (IPS, FTS or MSS)
Past hx of fam hx of: chromosomal anomaly or genetic dz, either parent a known carrier of a genetic d/o, consanguinity, >3 spontaneous abortions
Amniocentesis
U/S guided transabdominal extraction of amniotic fluid performed as early as 15wks GA
Screens for genetic anomalies and ONTD
Assessment of fetal lung maturity (T3) via L/S ratio (lecitihin:sphingomyelin), if >2:1 RDS is less likely to occur
Amniocentesis indications
Confirmation of positive NIPT
Positive FTS/IPS
Chorionic villus sampling
Biopsy of fetal derived chorion using transabdominal needle or transcervical catheter at 10-12wk
Screens for genetic d/o (rapid karyotyping and biocehmcial assay)
Does not screen for ONTD
Most common cause of DIC in pregnancy
Abruptio placentae
Dx of abruptio placentae
Clinical
U/S not sensitive for dx abruption
Stable abruption <37wk GA
Use serial Hct to assess concealed bleeding, deliver when feetus mature or when hemorrhage dictates
Stable abruption >/= 37wk
Deliver
Unstable abruption
Deliver (vaginal if no C/I, C/S otherwise)
Vasa previa
- Unprotected fetal vessels pass over cervical os
- A/W velamentous insertion of cord into membranes of placenta or accessory (succenturiate) lobe
- 1 in 500 deliveries
- Higher in twin pregnancies
- PAINLESS vaginal bleeding and fetal distress
- 50% perinatal mortality, increases to 75% if membranes rupture
Dx of vasa previa
Apt test
Wright stain on blood smear
Apt test
NaOH mixed with blood
Supernatant turns pink = fetal blood
Supernatant turns yellow = maternal blood
Wright stain on blood smear
Nucleated cells indicate cord blood
Tx of vasa previa
Planned C/s at 35-36wk
If bleeding, emergency C/S
Preterm labour
20-37wks GA
Most important risk factor for preterm labour
Previous history of spontaneous PTL
Cervical cerclage
Placement of cervical sutures at level of internal os, usually at end of first trimester (usually 12-12wk) or in second trimester and removed in third trimester
Progesterone to prevent preterm labour
- If previous PTL: 17-alphahydroxyprogesterone 250mg IM weekly from 16 - 36wks GA
- If short cervix: 200mg daily vaginally from time of dx to 36wks GA
Fetal fibronectin
Glycoprotein in amniotic fluid and placental tissue
+ve if >50ng/mL
Done only if 24-34wks, intact membranes, <3cm dilated, establish fetal well being
C/I if : cerclage, active vaginal bleeding, vag exam or sex in last 24h
If -ve: not likely to deliver in 7-14d
If +ve: increased risk of delivery
Tocolysis
Delays delivery for at least 48h for betamethasone valerate to work or for transfer to appropriate care centre
Only to be given if live, immature fetus, intact membranes, cervical dilatation of <4cm
Tocolytic agents
Nifedipine (20mg PO loading dose followed by 20mg PO 90min later, 20mg can be continued q3-8h for 72h or to a max of 180mg, 10mg PO q20min x 4doses)
Indomethacin = prostaglandin synthesis inhibitor, 1st line for early preterm labour (50-100mg PR loading dose followed by 50mg q6h x 8 doses for 48h)
Antenatal corticosteroids
Betamethasone valerate (12mg IM q24h x 2 doses)
Dexamethasone (6mg IM q12h x 4 doses)
Given btwn 24-36+6wks GA
Specific maternal C/I: Active TB
Prolonged ROM
> 24h elapsed btwn rupture of membranes and onset of labour
PPROM
<37wks GA and premature rupture of membranes
PPROM investigations
Pooling Cough test Nitrizine (blue) Ferning U/S
Antibiotics in PPROM
Give if there are no signs of immediate labour
Increases latency and decreases chorioamniotis
Ampicillin IV + Erythro IV x 48h then Amox PO x 5d + erythro PO x 5d OR just erythro PO x 10d
Postterm pregnancy IOL
> 39wks GA in advanced maternal age
>41wks GA if vagian ldelivery not C/I
Fetal demise
Fetal death after 20wks GA
Obstetrical causes of DIC
Abruption
Gestational HTN
Fetal demise
PPH
DIC specific b/w
Plt
aPTT and PT
FDP
Fibrinogen
DIC tx
Treat underlying cause Supportive Fluids Blood products FFP, plt, cryoprecipitate Consider anti-coagulation as VTE prophylaxis
IUGR
Estimated fetal weight <10th percentile for GA on U/S
TORCH infections
Toxoplasmosis Others (ie. syphilis) Rubella CMV HSV
Most important risk factor for IUGR
Previous IUGR
Symmetric/Type I IUGR
25-30%
Occurs early in pregnancy
* Reduced growth of both head and abdominal
* Head:Abdo ratio may be normal
* Usually a/w with congenital anomalies or TORCH infections
Asymmetric/Type II IUGR
70%
Occurs late in pregnancy
* Fetal abdo is disproportionately smaller than fetal head
* Brain is spared (Head:abdo ratio is increased)
* Usually a/w placental insufficiency
* More favourable prognosis than type I
Macrosomia
Infant weight >/=90th percentile for a particular GA or >4000g
U/S predictors of macrosomia
Polyhydramnios
Third trimester AC > 1.5cm/wk
HC/AC ratio <10th percentile
FL/AC ratio <20th percentile
Prophylactic C/S for macrosomia
EFW > 5000g in non-diabetic woman
EFW > 4500g in diabetic woman
Polyhydramnios
AFI>25cm
U/S deepest pocket >8cm
Management: mild-mod require no tx, severe should be hospitalized and consider therapeutic amnio
Oligohydramnios
AFI <5cm
U/S deepest pocket =2cm
Management: Admit, investigate, maternal hydration PO or IV, inject fluid via amnio, consider delivery
Med associated with oligohydramnios
ACEi
U/S frequency for multiple gestation
Serial U/S q2-3wk from 24wk GA to assess growth (uncomplicated didi)
Increased freq in monodi and monomono)
Vaginal delivery possible for twins if…
Twin A presents vertex
Time of cleavage for monoamniotic monochorionic twins
9-12d
Time of cleavage for diamniotic dichorionic twins
0-72h
Time of cleavage for diamnionic monochorionic twin
4-8d
Twin-Twin transfusion syndrome
Formation of placental intertwin vascular anastomoses causing arterial blood from donor twin to pass into veins of recipient twin
ECV
Has to be >36wk, singleton, unengaged presenting part, reactive NST, not in labour
If pt Rh neg, give Rhogam prior to procedure
Criteria for vaginal breech delivery
Frank or complete breech, GA > 36 wk
EFW 2500-3800g based on clinical and U/S assessment
Fetal head flexed
Continuous fetal monitoring
experienced clinicians
Ability to perform emergency C/S within 30min if required
Pre-existing HTN
BP >140/90 PRIOR TO 20wk GA, persisting >7wk postpartum
Gestational HTN
sBP >/= 140 or dBP >/= 90 after 20wk GA without proteinuria in a previously normotensive pt
More common in primigravida pts
Pre-eclampsia
Pre-existing or gestational HTN with new onset proteinuria or adverse conditions (end organ dysfunction)
Eclampsia
> /=1 generalized convulsions and/or coma in setting of preeclampsia and in absence of other neuro conditions
1/3 of cases have no proteinuria or BP > 140/90 prior to seizure
Ominous symptoms of HTN in pregnancy
RUQ pain
Headache
Visual disturbances
Placental growth factor (PIGF)
Lab test recommended to help rule out preeclampsia, insufficient evidence to recommend its use to rule in preeclampsia
Management of HTN
Labetalol 100-400mg PO BID-TID
or Nifedipine 20-60mg PO daily
or Alpha methyldopa 250-500mg PO BID-QID
Management of severe HTN
Labetalol 20mg IV t hen 20-80mg IV q30min (max 300mg) then switch to oral
Nifedipine 5-10mg capsule q30min
Hydralazine 5mg IV rpt q5-10mg IV q30min or 0.5-10mg/h IV to max of 20mg IV
Drugs to avoid to tx HTN in pregnancy
ACEi ARBs Diuretics Prazosin Atenolol
HELLP Syndrome
Hemolysis
Elevated Liver enzymes
Low Platelets
Seizure prevention/tx
MgSO4: 4g IV loading dose, followed by 1g/h (2g/h for treatment)
Risk of seizure highest in first 24h postpartum (cont MgSO4 for 12-24h after delivery)
Definitive treatment of eclampsia
Delivery
Tx for T2DM in pregnancy
Insulin
Targets in T2DM in pregnancy
FPG = 5.3mmol/L
1h post prandial PG = 7.8mmol/L
2h post prandial PG = 6.7 mmol/L
Monthly A1c
T2DM labour
Induce by 38-39wks
Consider elective C/S for predicted birthweight >4500g
Monitor blood glucose q1h with pt on insulin and dextrose drip
Aim for blood glucose 3.9-7mmol/L to reduce risk of neonatal hypoglycemia
Diabetes screening period
24-28wk GA
Diabetes screening options in pregnancy
- Fasting 75g OGTT; GDM if >/=1 of FPG >/= 5.1, 1h PG >/= 10, 2h PG >/= 8.5
- Random non-fasting 50g OGCT; GDM if 1h PG >/= 11.1, if 7.8-11 perform fasting 75g OGTT, GDM if >/=1 of FPG >/= 5.3, 1h PG >/= 10.6, 2h PG >/= 9
Postpartum followup for GDM
75g OGTT 6wk to 6mo postpartum
Congenital anomalies a/w diabetes in pregnancy
2-7x increased risk of congenital anomalies due to hyperglycemia from T1DM or T2DM
**NOT in GDM b/c it develops after critical period of organogenesis
GDM risk of progression to T2DM
50% in the next 20yr
GBS screening period
35-37wks GA
Risk factors for GBS
GBS bacteriuria Previous infant with invasive GBS infection Unkown GBS status with: - PTL <37wk - ROM >/= 18h before delivery - Intrapartum mat temp >/= 38C Positive GBS screen at 35-37wks
Indications for GBS abx prophylaxis
+ve GBS screen
GBS in urine
Previous infant with GBS
GBS unknown + one other risk factor
Abx for GBS
Give 4h prior to delivery
Pen G 5 million IU IV then 2.5 million IU IV q4h until delivery
If pen allergic but not anaphylactic: Cefazolin 2g IV then 1g q8h
If anaphylactically allergic to pen: Vanco 1g IV q12h until delivery
Tx of UTI in pregnancy
- 1st line: Amoxicillin 250-500mg PO q8h x 7d
- Alternatives: Nitrofurantoin 100mg PO BID x 7d or cephalosporins
- Follow with monthly urine cultures (recurrence is common)
Varicella vaccine during pregnancy
DO NOT administer
Live attenuated
Give VZIG if mother exposed to reduce congenital varicella syndrome
Congenital varicella syndrome
Limb aplasia Chorioretinitis Cataracts Cutaneous scars Cortical atrophy IUGR Hydrops
CMV implications to fetus
5-10% develops CNS involvement
Rubella vaccine during pregnancy
DO NOT administer
Live attenuated
No specific treatment during pregnancy
Congenital rubella syndrome
hearing loss, cataracts, CV lesions, MR, IUGR, hepatitis, CNS defects, osseous changes
Syphilis treatment
Pen G 2.4 million U IM x 1 dose if early, 3 doses if late
Monitor VDRL monthly
Congenital toxoplasmosis
Chorioretinitis, hydrocephaly, intracranial calcification, MR, microcephaly
Highest risk of DVT in pregancy
Third trimester and postpartum
Highest risk of PE in pregnancy
Postpartum (first 6wk)
Management of VTE in pregnancy
UFH 5000IU bolus followed by 30000IU/24h infusion
Measure aPTT 6h after bolus, maintain at therapeutic level (1.5-2x normal)
LMWH can also be used
Warfarin is C/I due to potential tertaogenic effects
Women with non-active PMHx of VTE mgmt during pregnancy
Unfractionated heparin regimens suggested
Preterm
> /=20 - = 36+6wk GA
Term
37 - 41+6wk GA
Postterm
> /= 42wk GA
Components of Bishop Score
Dilatation Effacement Consistency Position Station
Most common fetal position
Left OA
First stage of labour
0-10cm cervical dilation
Second stage of labour
10cm dilation - delivery of baby
Third stage of labour
Delivery of baby - delivery of placenta
Time limit for third stage of labour before interventions required
30min
Mgmt of placenta delivery
Oxytocin IV
Fourth stage of labour
First postpartum hour
Arteries and veins in placenta
2 arteries 1 vein
Early deceleration
Mirrors contraction
Benign
Due to vagal response to head compression
Variable deceleration
Often abrupt drop in FHR >15bpm below baseline with no effecto n baseline FHR (>15s for <2 min)
Due to cord compression or in second stage pushing with contractions
Complicated variable decels
FHR drop <70bpm for >60s
Loss of variability or decrease in baseline after decel
Slow return to baseline
May be associated with fetal acidemia
Late decels
Decels occuring after peak of contraction, slow return to baseline
ay cause decreased variabilty and change in baseline FHR
pH measurement for fetal scalp blood sampling
> /=7.25, lactate <4.2 = normal, repeat if abnormal FHR persists
7.21-7.24, lactate 4.2-4.8 = repeat assessment in 30 min or consider delivery if rapid fall since last sample
= 7.20, lactate >4.8 = indicated fetal acidosis, delivery is indicated
Redistribution of fetal blood flow in response to hypoxia/asphyxia
Increased blood flow to brain, heart, adrenals
Decreased blood flow to kidneys, lungs, gut, liver, peripheral tissues
Increase in BP
Bishop score scoring
Cervix considered unfavourable if <6
Favourable if >/=6
9-13 = high likelihood of vaginal delivery
Maternal indications for labour induction
DM Gestational HTN >/= 37wk Preeclampsia Other maternal medical problems (ie. renal or lung dz, chronic HTN, cholestasis) Maternal age >40
Maternal-fetal factors for labour induction
Isoimmunization
PROM
Chorioamnionitis
Cervical ripening methods
Prostaglandins (PGE2)
PGE1 (Misoprostol)
Foley catheter placement
Opioid in labour management
Morphine in latent stage
Fentanyl in active stage/second stage
Labour induction agent
Oxytocin
Labour augmentation agent
Oxytocin
4 Ps of dystocia
Power (leading cause)
Passenger
Passage
Psyche
Dystocia in active phase
> 4h of < 0.5cm/h
Dystocia in 2nd phase
> 1h with no descent during active pushing
Brachial plexus injury, Erb’s palsy
C5-7
Brachial plexus injury, Klumpke’s palsy
C8-T1
Most common presentation of uterine rupture
Prolonged fetal bradycardia
Placenta accreta
Placenta grows too deeply into uterine wall
Placental abruption
Placenta detaches from uterine wall before birth
Amniotic fluid embolus
Amniotic fluid debris in maternal circulation triggering an anaphylactoid immunologic response
Sudden onset resp distress, CV collapse, coagulopathy, sz in 10%
Leading cause of maternal death in induced abortions and miscarriages
Amniotic fluid embolus
Chorioamnionitis
Infection of chorion, amnion, amniotic fluid typically due to ascending infections by organisms of normal vaginal flora
Predominant microorganisms in chorioamnionitis
GBS Bacteroides Prevotella E.Coli Anaerobic streptococcus
Treatment for chorioamnionitis
Ampicillin 2g IV and gentamicin 2mg/kg load then 1.5mg/kg IV q8h or 5mg/kg IV q24h Anaerobic coverage (ie. clindamycin 900mg IV q8h) If at risk for endometritis, continue postpartum NOT and indication for immediate delivery or C/S
Meconium
More common in postdate pregnancies
Always abnormal in preterm fetus
Likely due to cord compression +/- uterine hypertonia
Outlet forceps position
Head visible btwn labia in btwn contractions
Low forceps position
Presenting part at station +2 or greater
Mid-forceps position
Presenting part below spines but above station +2
Vacuum extraction C/I
<34wk GA (<2500g)
Fetal head deflexed
Fetus requires rotation
Fetal condition (ie. bleedng d/o)
Limits for trial of vacuum
After 3 pulls over 3 contractions with no progress
After 3 pop offs with no obvious cause
20min and delivery is not imminent
1st degree laceration
Skin and vaginal mucosa but not underlying fascia and muscle
2nd degree laceration
Fascia and muscles of perineal body but not anal sphincter
3rd degree laceration
Involves anal sphincter
Single prophylactic dose of IV abx should be administered
4th degree laceration
Extends through anal sphincter into rectal mucosa
Single prophylactic dose of IV abx should be administered
Episiotomy
Essentially controlled 2nd degree laceration
Midline (heals better, increased risk of 3/4th degree tears) or mediolateral (less risk of tear, more painful)
7 layers to dissect through in C/S
Skin Fat Fascia Rectus abdominus Peritoneum Bladder flap Uterus
Layers of rectus sheath
Above arcuate line: External oblique, external internal oblique, internal oblique, rectus abdominis, internal internal oblique, transversus abdominis
Below arcuate line: External oblique, internal oblique, transversus abdominis, rectus abdominis
Name of obliterated umbilical ligament
Urachus
C/I to VBAC
Previous classical, inverted T or unknown uterine incisions or complete transection of uterus
Hx of uterine surgery (ie. myomectomy) or previous uterine rupture
Multiple gestation
Non-vertex presentation or placenta previa
Inadequate facilities or personnel for emergency C/S
Puerperium
6wk post partum
Postpartum hemorrhage
Loss of >1000mL of blood within 24h of birthing process regardless of mode of delivery
Primary = within first 24h
Secondary = after 24h but within first 12wk
4 Ts of PPH
Tone (most common cause)
Tissue
Thrombin (vDW = most common)
Trauma
Avoid tone causing PPH via:
- Oxytocin 10U IM or 20-40IU in 1000cc crystalloid at 150mL/h
- Uterine massage
- Umbilical cord traction
Carbetocin
Long-acting oxytocin
Consider as alternative to continuous infusion in elective C/S or vaginal deliveries with 1 risk factor for PPH
Ergotamine/Methylergonavine maleate
0.25mg IM q15min up to 1.25mg
Can be given as IV bolus of 0.125mg
May exacerbate HTN (avoid in HTN pts or pts on HIV meds)
Hemabate/Carboprost
Synthetic PGF-1alpha analog
250ug IM q15min to max 2mg
C/I in CV, pulmonary, renal, and hepatic dysfunction (ie. asthma)
Misoprostol for PPH
600-800ug PO/SL or PR/PV
Not as effective
TXA for PPH
Antifibrinolytic
1g IV
Bakri balloon
Used to tamponade PPH to slow hemorrhage
Surgical tx for intractable PPH
D&C
Embolization of uterine artery or internal iliac artery
laparatomy with bilateral ligation of uterine artery, ovarian artery or hypogastric artery
Hysterectomy as last option
Retained placenta
Placenta undelivered after 30min postpartum
Retained placenta mgmt
Brant maneuver (traction on cord while applying suprapubic pressure to avoid uterine inversion)
Oxytocin 10IU in 20mL NS into umbilical vein
Manual removal or D&C if all else fails
Cefazole 2g IV if manual removal or D&C
Endometritis treatment
Clindamycin and gentamicin IV
Mastitis
Cloxacillin or cephalexin
Continue nursing
If abscess develops, d/c nursing and start IV abx (oxacillin) + I&D
Postpartum blues
Self limited
Resolves by 2 weeks
Postpartum depression
Major depression occuring in a woman within 6mo of childbirth
Postpartum psychosis
Onset of psychotic symptoms over 24-72h within first month postpartum
Time for ovulation to resume
~45d for non-lactating women
3-6mo for lactating women and sometimes later
Galactogogues
DA antagonists
Domperidone, metoclopramide
Meds C/I when BF
Cyclophosphamides Sulphonamides (in G6PD deficiency) Nitrofurantoin (in G6PD deficiency) Tetracycline Lithium Bromocriptine Antineoplastic and immunosuppressants Psychotropic drugs
Uterine rupture presentation during labour
Repetitive variable decels
Vaginal bleeding
Presenting part no longer palpable
Persistent pelvic pain
Most common cause of jaundice in pregnancy
Viral hepatitis
Accounts for 50% of all cases
Cholestasis of pregnancy
Pruritus often worse on palms and soles at night RUQ pain Nausea Jaundice RARE High serum bile acid concentrations (>/= 40 increased risk to fetus, >/= 100 risk for fetal demise) Typically late 2nd or 3rd trimester Resolves rapidly after delivery Most common liver disease in pregnancy
Cholestasis of pregnancy mgmt
Treat all
If suspected but labwork normal, tx empirically OR rpt lab tests weekly
Ursodeoxycholic acid 300mg BID-TID until delivery
Follow with modified BPP 2x/wk
May have increased NSTs
Deliver usually at 36 - 36+6wks
Recheck LFTs/bile acids 6-8wks after delivery
Velamentous cord insertion
Umbilical cord inserts into choriamniotic membranes then travels within membranes to placenta (btwn amnion and chorion)
Exposed vessels are not protected by Wharton’s jelly
Triple screen
AFP, HCG, uE3 Considers age-related risk for aneuploidy for each of the markers --> predicts risk for both trisomy 21 and trisomy 18 All 3 are low in tri 18 Tri 21 has low AFP Tri 13 can't be screened by low AFP
AFP in open neural tube defects
Elevated
Cervical insufficiency
Inability of uterine cervix to retain a pregnancy in the second trimester, in the absence of uterine contractions
Biochemical changes a/w cervical insufficiency
Decreased collagen concentration Increased collagen solubility Increased interleukin 8 Increased glycosaminoglycans Increased tissue hydration
First step in assessing infertility
Sperm analysis
Normal sperm analysis
> 2mL volume
Sperm motility >50%
Sperm density >20million
Ovulation and basal body temperature
Temp rises as progesterone is secreted just after ovulation
Ovulation occurs JUST BEFORE temperature rises
Sometimes there is a temperature drop during ovulation
Cholesterol in pregnancy
Increases
Albumin in pregnancy
Decreases due to dilution
Fasting glucose in pregnancy
Drops due to increased storage of tissue glycogen, increased peripheral glucose utilization, decreased hepatic glucose production, glucose consumption by fetus
Bicarb in pregnancy
Decreases as kidney excretes more to compensate for drop in CO2 (due to increase in minute ventilation)
Contraction stress test
Positive indicates late decels are present on at lesat 50% of contractions
Preventative measures for women at increased risk of eclampsia
ASA 75-162mg/d taken at bedtime, start BEFORE 16wks GA and continue until delivery
Calcium supplementation
No EtOH, peri-conceptual use of folate-containing multivitamin, smoking cessation
Personal risk factors for pre-eclampsia
First pregnancy New partner <18yo or >35yo Hx of preeclampsia Family hx of preeclampsia in 1st degree relative Black race Obesity Interpreg interval <2y or >10y
Medical risk factors for pre-eclampsia
Chronic HTN Pre-existing diabetes Renal dz SLE Obesity Thrombophilia Hx of migraine SSRI use beyond 1st trimester
2nd trimester DS lab results
AFP: 25% lower than normal
hCG: 2x higher than normal
Hormone responsible for development of milk producing alveolar cells in breast tissue during pregnancy
Progesterone
Hormone produced via suckling reflex to cause contraction of smooth muscle cells in ducts to eject milk from nipple
Oxytocin
Hormone responsible for stimulating alveolar cells to produce milk
Prolactin
High progesterone during pregnancy inhibits prolactin from inducing milk synthesis
Hormone involved in gestational diabetes
Human Placental Lactogen
BMI < 18.5 can expect to gain…
<12.5-18kg
BMI 18.5-25 can expect to gain
11.6-16kg
BMI >18.5 can expect to gain
7-11.5kg
When to do Leopold maneuvers
> 30wks
Factors a/w decreased success of VBAC:
BMI >/= 40 >/=2 C/S without vaginal delivery in the past Previous C/S for failure to progress Maternal age of >35yrs Infant weight >/= 4000g Requirement for induction of labour
Length of cervix that is considered short and would require cervical cerclage
<25mm
Missed abortion
Dead fetus with closed cervix and no passage of products
Complete abortion
Products of conception are passed and cervix is closed
Threatened abortion
Bleeding but closed cervix. No products of conception passed.
Incomplete abortion
Bleeding, open os, products of conceptions seen at os or vault
Antiphospholipid syndrome
A/w false +VDRL, prolonged PTT, thrombocytopenia
Prophylaxis with low dose ASA, LMWH
Tx of Grave’s in pregnancy
Propylthiouracil in first trimester
Methimazole in 2nd and 3rd trimesters
Magnesium toxicity signs
Lack of patellar reflexes –> respiratory depression –> cardiac conduction changes –> cardiac arrest
Zika virus and pregnancy planning
Wait 2 mo for women
Wait 6 mo for men